Nicholas F LaRusso (Nicholas LaRusso)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Hepatology communications

Liver international : official journal of the International Association for the Study of the Liver

Research square

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Brian D Juran, Bryan M McCauley, Elizabeth J Atkinson, Erik M Schlicht, Jackie K Bianchi, Jason M Vollenweider, Hong Ye, Nicholas F LaRusso, Gregory J Gores, Zhifu Sun, Konstantinos N Lazaridis
Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease. Hepatology communications 8 (8) (2024)
Brian D Juran, Bryan M McCauley, Elizabeth J Atkinson, Erik M Schlicht, Jackie K Bianchi, Jason M Vollenweider, Hong Ye, Nicholas F LaRusso, Gregory J Gores, Zhifu Sun, Konstantinos N Lazaridis
Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease. Hepatology communications 8 (8) (2024)
Stella Victorelli, Madeline Eppard, Seung-Hwa Woo, Stacia Everts, Helene Martini, Nicholas Pirius, Ana Catarina Franco, Yeaeun Han, Dominik Saul, Patrick Splinter, Steven O'Hara, Lucia Valenzuela-Pérez, Hyun Se Kim Lee, Diana Jurk, Nicholas F LaRusso, Petra Hirsova, João F Passos
Mitochondrial RNA cytosolic leakage drives the SASP. Research square (2024)
Brian D Juran, Bryan M McCauley, Elizabeth J Atkinson, Erik M Schlicht, Jackie K Bianchi, Jason M Vollenweider, Hong Ye, Nicholas F LaRusso, Gregory J Gores, Zhifu Sun, Konstantinos N Lazaridis
Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease. Hepatology communications 8 (8) (2024)
Christy E Trussoni, Steven P O'Hara, Nicholas F LaRusso
Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target. Seminars in immunopathology 44 (4) (2022)
Takahiro Nishio, Yukinori Koyama, Xiao Liu, Sara B Rosenthal, Gen Yamamoto, Hiroaki Fuji, Jacopo Baglieri, Na Li, Laura N Brenner, Keiko Iwaisako, Kojiro Taura, James S Hagood, Nicholas F LaRusso, Tapan K Bera, Ira H Pastan, David A Brenner, Tatiana Kisseleva
Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis. Proceedings of the National Academy of Sciences of the United States of America 118 (29) (2021)
Mohammed S Al Suraih, Christy E Trussoni, Patrick L Splinter, Nicholas F LaRusso, Steven P O'Hara
Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor. Liver international : official journal of the International Association for the Study of the Liver 40 (10) (2020)